Valuation: ConvaTec Group PLC

Market Cap 5.57B 97.27B 4.87B 4.5B 4.2B 7.91B 526B 8.05B 53.95B 20.95B 260B 20.91B 20.45B 905B P/E 2026 *
20.1x
P/E 2027 * 15.4x
Enterprise Value 6.77B 118B 5.92B 5.47B 5.1B 9.61B 640B 9.78B 65.57B 25.45B 316B 25.42B 24.85B 1,100B EV / Sales 2026 *
2.64x
EV / Sales 2027 * 2.41x
Free-Float
95.19%
Yield 2026 *
2.77%
Yield 2027 * 3.11%
1 year 59.76
Extreme 59.76
60.46
3 years 57.13
Extreme 57.13
74.97
5 years 57.13
Extreme 57.13
74.97
10 years 57.13
Extreme 57.13
74.97
Manager TitleAgeSince
Chief Executive Officer 62 03/08/2025
Director of Finance/CFO 51 03/08/2025
Chief Operating Officer - 31/05/2026
Director TitleAgeSince
Director/Board Member 71 13/08/2017
Chairman 78 29/09/2019
Director/Board Member 62 01/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-.--% - - 5.54B
-1.94%+0.79%-32.91%-16.30% 161B
-2.65%-1.96%-9.32%-10.27% 104B
+0.62%+1.18%-5.14%+47.81% 54.8B
+0.56%-3.80%+53.05%+53.64% 53.31B
-2.08%+5.69%-11.69%-42.38% 42.76B
-0.98%+11.06% - - 33.49B
-2.88%-1.01%-21.84%-46.91% 27B
+0.99%+6.30%+63.42%-6.51% 25.06B
-1.38%+3.43%-12.51%-6.58% 20.78B
Average -1.09%+5.30%+2.88%-3.44% 58.03B
Weighted average by Cap. -1.38%+4.65%-7.15%-3.27%

Financials

2026 *2027 *
Net sales 2.57B 44.85B 2.25B 2.07B 1.93B 3.65B 243B 3.71B 24.88B 9.66B 120B 9.64B 9.43B 417B 2.74B 47.86B 2.4B 2.21B 2.06B 3.89B 259B 3.96B 26.54B 10.31B 128B 10.29B 10.06B 445B
Net income 277M 4.83B 242M 224M 209M 393M 26.16B 400M 2.68B 1.04B 12.91B 1.04B 1.02B 44.97B 365M 6.37B 319M 295M 275M 518M 34.48B 527M 3.53B 1.37B 17.01B 1.37B 1.34B 59.28B
Net Debt 1.2B 20.93B 1.05B 968M 903M 1.7B 113B 1.73B 11.61B 4.51B 55.9B 4.5B 4.4B 195B 1.03B 17.99B 901M 832M 776M 1.46B 97.35B 1.49B 9.98B 3.87B 48.04B 3.87B 3.78B 167B
Logo ConvaTec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.832USD
Average target price
3.988USD
Spread / Average Target
+40.81%

Quarterly revenue - Rate of surprise